On December 23, 2015, an objection to the motion for authority to sell assets of the estates pursuant to section 363 of the Bankruptcy Code was filed in the bankruptcy case of Cardiac Science Corporation and its affiliates.
The filing was assigned docket number 323 and is described on the court’s official docket as follows:
Objection filed by Daniel R Freund on behalf of Oracle America, Inc.. Related document(s),  Motion to Sell Property Free and Clear of Liens under Section 363(f) Motion, Pursuant to Bankruptcy Code Sections 105(a), 363, 365, 503, and 507 and Bankruptcy Rules 2002, 3007, 6004, 6006, 9007, and 9014, for Entry of: (a) Order (i) Approving Biddi filed by Debtor Cardiac Science Corporation, Notice of Filing filed by Debtor Cardiac Science Corporation.(Freund, Daniel)
Cardiac Science Corporation filed for bankruptcy protection, or had an involuntary bankruptcy petition filed against it, on October 20, 2015. The bankruptcy case is pending before the United States Bankruptcy Court for the Western District of Wisconsin. The case number for the lead bankruptcy case is 15-13766. The bankruptcy case is currently assigned to United States Bankruptcy Judge Robert Martin . The law firm of Whyte Hirschboeck Dudek S.C. is acting as lead bankruptcy counsel to Cardiac Science Corporation in the bankruptcy case.